Swedish healthcare company KRY raised $66 million (53 million euros) in Series B funding round led by international venture capital firm Index Ventures with participation from existing investors Accel, Creandum, and Project A.
KRY will use the investment to continue building its world-class team in order to further expand geographically initially to the UK and France, deepen penetration in existing markets.
The company also plans to expand its medical offering and reach its goal of becoming the healthcare provider by combining medical expertise with state-of-the-art technology.
In June 2017, KRY raised 20 million euros in a Series A round led by Accel.